← Back

$ Value

$0

Shares

589

Price

$0

Filed

Feb 18

Insider

Name

Wilder Thomas

Title

CIK

0001491299

Roles

Director

Transaction Details

Transaction Date

2026-02-13

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

589

Footnotes

Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Mr. Wilder's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Mr. Wilder's continued service as director through such date. | A portion of these shares is subject to vesting. | Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006.

Filing Info

Accession No.

0001491299-26-000004

Form Type

4

Issuer CIK

0001321732

Wilder Thomas's History

Date Ticker Type Value
2026-02-13 PEN A $0
2026-01-02 PEN $58K
2025-10-01 PEN $47K
2025-08-12 PEN $89K

Other Insiders at PEN (90d)

Insider Bought Sold Last
Grewal Harpreet $33K 2026-04-02
Bose Arani 2026-02-13
O'Rourke Bridget 2026-02-13
Roberts Johanna
EVP, Gen. Counsel & Secretary
2026-02-17
Leeds Janet 2026-02-13
Sarna Surbhi 2026-02-13
Yuen Maggie
Chief Financial Officer
2026-02-17
Shiu Lambert
Chief Accounting Officer
2026-02-17
Narayan Shruthi
President
2026-02-17